DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.

Fabien Despas; Atul Pathak; M. Berry; R. Cagnac; P. Massabuau; E. Liozon; Michel Galinier; Jean-Michel Senard

doi:10.1007/s10286-009-0049-7

Journal articles

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.

Fabien Despas ^{1, 2, 3, *} Atul Pathak ^{1, 3} M. Berry ⁴ R. Cagnac ⁵ P. Massabuau ⁴ E. Liozon ⁶ Michel Galinier ⁴ Jean-Michel Senard ^{1, 3}

* Corresponding author

1 Department of Clinical Pharmacology

2 Laboratoire de Pharmacologie clinique

3 I2MR - Institut de médecine moléculaire de Rangueil

4 Service de cardiologie [Toulouse]

5 CHU - Department of Nuclear Medicine, CHU de Toulouse

6 Service de Médecine interne A et polyclinique médicale [CHU Limoges]

Abstract : We describe the effects of chronic droxidopa in a patient with Dopamine beta-hydroxylase deficiency diagnosed at the age of 73. Investigations were performed to assess sympathetic activity (MIBG scintigraphy, catecholamines) and cardiovascular droxidopa safety.

Document type :

Journal articles

Complete list of metadata

https://www.hal.inserm.fr/inserm-00504967
Contributor : Marie Francoise Simon Connect in order to contact the contributor
Submitted on : Thursday, July 22, 2010 - 10:09:59 AM
Last modification on : Wednesday, June 1, 2022 - 5:00:55 AM

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.

Links full text

Identifiers

Collections

Citation

Export

Metrics

25

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

25